Harrison.ai

Active#11 in Australia

Clinical AI, sold as Annalise.ai, that helps radiologists and pathologists read medical images and slides.

Healthtech›radiology and pathology AI harrison.ai

Founded2018

HQSydney

RaisedUSD 240M+

Last roundSeries C · Feb 2025

Country of originAustraliaListed in the Australia ranking

Where would you invest?AustraliaJurisdiction as cited by the ranking

Uback rankings

How the AI ranks →

Ranking	Tier	Rank	Edition	Next update
Australia · all sectors	Top 45	#11	Edition 0 · October 2026	7 Jan 2027

Rank historyOct 2026 · #11First edition: no movements yet.

Estimated valuation

AI · Australia ranking

≈ USD 580MUSD 460–720M · Hundreds of M$

Hundreds of k$

Millions $

Tens of M$

Hundreds of M$

Unicorn

Decacorn

Hectocorn

Anchor: Last known equity round: Series C · USD 112M · Feb 2025
AI adjustment: None

An indicative editorial estimate produced by AI, imperfect by nature: neither a financial valuation nor investment advice. Only the market sets a company’s value. Method

Funding history

USD 240M+ raised in total

Date	Round	Amount	Type	Investors
Feb 2025	Series C	USD 112M (AUD 179M)	Equity	Aware Super, ECP, Horizons, NRFC, Blackbird

Rounds as cited by Uback’s rankings. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of Harrison.ai as a PDF. It must answer at least one of these four questions, and stick to them:

AI valuation: $580MUndervalued or overvalued?

Versus competitorsHow does it compare?

Who should acquire itStrategic buyers, and why

Who should it acquireAcquisition targets, and why

Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication.

Invest

Back Harrison.ai whether or not it has agreed: your intention joins the pool on Harrison.ai, passed to the local partner once it reaches critical mass. Backing on Uback (pronounced “you back”) means declaring an Interest (free) or an Intention (coming soon). Backing does not mean that this company is raising funds or that a shareholder is selling shares, and it is not a commitment to invest. Any deal, through a funding round or a sale by an existing shareholder, is handled by a local partner.

Back Harrison.ai Or back healthtech in Australia

Pool on Harrison.aiBelow threshold

BackersBelow threshold

Paid intention · valid for life · movable until a deal process opens. If the company does not follow up, Uback invites its Backers to move their intentions to a competitor or a similar company. Investing in non-listed companies carries a risk of losing all the capital invested.

Do you run Harrison.ai?

Claim this profile to correct data, add your logo and description, or tell Uback about an upcoming round.

Claim this profile Report an upcoming round → Report an error →

Are you a shareholder?

Considering selling some of your shares? Tell Uback privately. Nothing is published without your consent, and never a price or a volume.

Tell Uback privately

What the AI reads

Read by the AI at the next edition.

Comparable companies in Australia

Full Australia ranking →

Mable#6Healthtech › home-care marketplaceUnicorn Heidi Health#8Healthtech › AI clinical assistantHundreds of M$Everlab#27Healthtech › preventive healthHundreds of M$Splose#35Healthtech › practice management for allied healthHundreds of M$

Investors in Harrison.ai: Aware Super · ECP · Horizons · NRFC · Blackbird

Last updated: Oct 2026Report an error

Uback is a content publisher and an aggregator of non-binding expressions of interest. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.